Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is seeking a Director of Artificial Intelligence to lead the expansion of AI capabilities across the Research organization. This role involves establishing and leading a team to design and deploy next-generation agentic workflows that integrate into scientific research and the discovery of novel siRNA therapeutics. The position requires partnering with Research teams to embed AI into daily scientific workflows, enabling faster, more scalable, and more reproducible discovery processes.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alnylam Pharmaceuticals.
Director of Artificial Intelligence
alnylam
Senior Scientist, AI for Discovery — New Target Discovery
AstraZeneca
Associate Director Digital Proteomics And Ai Innovation Gaithersburg Maryland United States Of America
AstraZeneca
Fellow
c10labs
Senior Scientific Director siRNA (m/f/d)
City of Duncan, Oklahoma
Principal Scientist, Systems and Disease Biology
sanofi us